Sleiman Robert J, Gray Peter P, McCall Martin N, Codamo Joe, Sunstrom Noelle-Ann S
ACYTE Biotech Pty Ltd., University of New South Wales, Sydney, NSW, Australia.
Biotechnol Bioeng. 2008 Feb 15;99(3):578-87. doi: 10.1002/bit.21612.
The success of engineered monoclonal antibodies as biopharmaceuticals has generated considerable interest in strategies designed to accelerate development of antibody expressing cell lines. Stable mammalian cell lines that express therapeutic antibodies at high levels typically take 6-12 months to develop. Here we describe a novel method to accelerate selection of cells expressing recombinant proteins (e.g., antibodies) using multiparameter fluorescence activated cell sorting (FACS) in association with dual intracellular autofluorescent reporter proteins. The method is co-factor-independent and does not require complex sample preparation. Chinese hamster ovary (CHO) clones expressing high levels of recombinant antibody were selected on the basis of a two-color FACS sorting strategy using heavy and light chain-specific fluorescent reporter proteins. We were able to establish within 12 weeks of transfection cell lines with greater than a 38-fold increase in antibody production when compared to the pool from which they were isolated, following a single round of FACS. The method provides a robust strategy to accelerate selection and characterization of clones and builds a foundation for a predictive model of specific productivity based upon on two-color fluorescence.
工程化单克隆抗体作为生物制药的成功,引发了人们对旨在加速抗体表达细胞系开发策略的浓厚兴趣。能够高水平表达治疗性抗体的稳定哺乳动物细胞系通常需要6到12个月才能开发出来。在此,我们描述了一种使用多参数荧光激活细胞分选(FACS)结合双细胞内自发荧光报告蛋白来加速选择表达重组蛋白(如抗体)细胞的新方法。该方法不依赖辅因子,也不需要复杂的样品制备。基于使用重链和轻链特异性荧光报告蛋白的双色FACS分选策略,筛选出了高水平表达重组抗体的中国仓鼠卵巢(CHO)克隆。在转染后的12周内,通过一轮FACS,我们能够建立起抗体产量比其分离来源的细胞池增加超过38倍的细胞系。该方法为加速克隆的选择和鉴定提供了一个强有力的策略,并为基于双色荧光的比生产率预测模型奠定了基础。